Sensitive Skin Clinical Trial
— SENSISKINOfficial title:
Quantitative Sensory Testing in Subjects With Sensitive Skin or Not
Verified date | October 2017 |
Source | University Hospital, Brest |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Sensitive skin is a common problem, with 50% of women and 30% of men in Europe feel they have
sensitive skin.
The Quantitative sensory testing (QST) is a physico-psychic method that uses gradients
stimuli of different modalities to measure a subjective somatosensory response. This allows
to characterize sensory dysfunction by assessing the participation of small and large nerve
fibers.
The aim of this project is to characterize the presence or absence of a neurological disorder
in patients with sensitive skin. This discovery would be a decisive argument to reinforce the
suspicion that sensitive skins is linked to a small fiber neuropathy.
Status | Completed |
Enrollment | 42 |
Est. completion date | October 17, 2017 |
Est. primary completion date | September 22, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Age: between 20 and 60 years - Cooperating patient - Informed and written consent of the subject - Affiliated to the social security - For subjects with sensitive skin: subjects with a score greater than 50 on the scale sensitive scale - To control subjects: subjects with result of less than 20 sensitive to the scale scale Exclusion Criteria: - Adults subject with legal protection - Subject in a social institution. - Subject with major cognitive or psychiatric disorders - Subject with pathological use of alcohol or consumption of another drug. - Subject with skin involvement of the back of the dominant hand or malformation. - Known sensitive neuropathy - Pregnant woman - Subject receiving medical treatment which may interfere with the results. - Subject with treatment in the back of the dominant hand. |
Country | Name | City | State |
---|---|---|---|
France | CHRU de Brest | Brest |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cutaneous perception threshold | The cutaneous perception threshold of pain to heat. | 6 months | |
Secondary | The cutaneous perception threshold of vibration | The cutaneous perception threshold of pain to harm. | 6 months | |
Secondary | The cutaneous perception threshold of cold | The cutaneous perception threshold of cold | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05094700 -
A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants
|
N/A | |
Enrolling by invitation |
NCT01871883 -
TRPV Expression in Subjects With Sensitive Skin
|
Phase 4 | |
Active, not recruiting |
NCT04898582 -
Clinical Benefit of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin
|
N/A | |
Completed |
NCT03279003 -
Study of the Efficacy and Tolerance of Light Therapy in Sensitive Skin
|
N/A | |
Completed |
NCT03464890 -
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area
|
N/A | |
Completed |
NCT05630027 -
A Scalp Lotion Toimprove Sensitive Scalp Syndrome
|
||
Completed |
NCT03958968 -
Impact of Exposure to Cosmetics on Sensitive Skin
|